Biotransformations of Anticancer Ruthenium(III) Complexes: An X‐Ray Absorption Spectroscopic Study

An anti‐metastatic drug, NAMI‐A ((ImH)[Ru^IIICl₄(Im)(dmso)]; Im=imidazole, dmso=S‐bound dimethylsulfoxide), and a cytotoxic drug, KP1019 ((IndH)[Ru^IIICl₄(Ind)₂]; Ind=indazole), are two Ru‐based anticancer drugs in human clinical trials. Their reactivities under biologically relevant conditions, including aqueous buffers, protein solutions or gels (e.g, albumin, transferrin and collagen), undiluted blood serum, cell‐culture medium and human liver (HepG2) cancer cells, were studied by Ru K‐edge X‐ray absorption spectroscopy (XAS). These XAS data were fitted from linear combinations of spectra of well‐characterised Ru compounds. The absence of XAS data from the parent drugs in these fits points to profound changes in the coordination environments of Ru^III. The fits point to the presence of Ru^IV/III clusters and binding of Ru^III to S‐donor groups, amine/imine and carboxylato groups of proteins. Cellular uptake of KP1019 is approximately 20‐fold higher than that of NAMI‐A under the same conditions, but it diminishes drastically after the decomposition of KP1019 in cell‐culture media, which indicate that the parent complex is taken in by cells through passive diffusion.     

[RuCl3ind3] and [RuCl2ind4]: Two New Ruthenium Complexes derived from the Tumor‐inhibiting RuIII Compound HInd (OC‐6‐11)‐[RuCl4ind2] (ind = indazole)

Indazolium (OC‐6‐11)‐tetrachlorobis(indazole) ruthenate(III), HInd (OC‐6‐11)‐[RuCl₄ind₂], exhibits excellent results in different tumor models in vitro and in vivo. Substitution reactions of this ruthenium(III) complex are of special interest for a deeper understanding of its interactions with biologically occurring targets and its mode of action. The indazolium complex salt can be transformed to the neutral, meridionally configurated trisindazole complex (OC‐6‐21)‐[RuCl₃ind₃] in solvents like tetrahydrofuran. The X‐ray crystal structure of this complex could be solved (monoclinic space group P2(1)/n, a = 12.441(3), b = 10.415(3), c = 21.635(4) Å, β = 105.02(1)°). In spite of the paramagnetic Ru^III atom most of the coordinated indazole protons could be assigned with the help of two‐dimensional NMR experiments. Additionally, a reduced reaction product of HInd (OC‐6‐11)‐[RuCl₄ind₂] in the physiological solubilizer 2‐pyrrolidone could be isolated and the X‐ray crystal structure of this Ru^II complex, (OC‐6‐12)‐[RuCl₂ind₄], crystallized with two 2‐pyrrolidones, could be solved (monoclinic space group P2(1)/n, a = 12.139(2), b = 10.426(2), c = 14.426(3) Å, β = 100.06(3)°).     

Ruthenium(II/III)‐Based Compounds with Encouraging Antiproliferative Activity against Non‐small‐Cell Lung Cancer

Hereby we present the synthesis of several ruthenium(II) and ruthenium(III) dithiocarbamato complexes. Proceeding from the Na[trans‐Ru^III(dmso)₂Cl₄] ( 2 ) and cis‐[Ru^II(dmso)₄Cl₂] ( 3 ) precursors, the diamagnetic, mixed‐ligand [Ru^IIL₂(dmso)₂] complexes 4 and 5 , the paramagnetic, neutral [Ru^IIIL₃] monomers 6 and 7 , the antiferromagnetically coupled ionic α‐[Ru^III₂L₅]Cl complexes 8 and 9 as well as the β‐[Ru^III₂L₅]Cl dinuclear species 10 and 11 (L=dimethyl‐ (DMDT) and pyrrolidinedithiocarbamate (PDT)) were obtained. All the compounds were fully characterised by elemental analysis as well as ¹H NMR and FTIR spectroscopy. Moreover, for the first time the crystal structures of the dinuclear β‐[Ru^III₂(dmdt)₅]BF₄ ? CHCl₃ ? CH₃CN and of the novel [Ru^IIL₂(dmso)₂] complexes were also determined and discussed. For both the mono‐ and dinuclear Ru^II and Ru^III complexes the central metal atoms assume a distorted octahedral geometry. Furthermore, in vitro cytotoxicity of the complexes has been evaluated on non‐small‐cell lung cancer (NSCLC) NCI‐H1975 cells. All the mono‐ and dinuclear Ru^III dithiocarbamato compounds (i.e., complexes 6 – 10 ) show interesting cytotoxic activity, up to one order of magnitude higher with respect to cisplatin. Otherwise, no significant antiproliferative effect for either the precursors 2 and 3 or the Ru^II complexes 4 and 5 has been observed.     

Synthesis,characterization and reactivity studies of dichloroacetylacetonato acetylacetone ruthenium(III)

Summary The Ru^III complex [RuCl₂(acac)(acacH)] (acacH = acetylacetone) was isolated in high yield by reacting RuCl₃ with acacH. The compound was used as a convenient starting material for the synthesis of a variety of Ru^III complexes, viz. [RuCl₂(acac)L₂] (L = PPh₃, AsPh₃, py, MeCN, Me₂SO, o-phenylenediamine; L₂ = phen or bipy) and M₂[RuCl₄(acac)] (M = Me₄N, Rb or Cs). The compounds were characterized by physicochemical and spectroscopic methods.     

Studies on ruthenium(III), rhodium(III) and iridium(III) complexes of indazoles

Summary New complexes of the general formula M(L)₃Cl₃ and M(5-AInz)₂Cl₃ · n H₂O (where M = Ru^III, Rh^III and Ir^III; L = indazole and 5-nitroindazole; n=1–2) have been synthesized and characterised by elemental analysis, molar conductance, magnetic susceptibility and i.r. and electronic spectral measurements. All the complexes are covalent and apparently have an octahedral geometry. The ligands are monocoordinated through the pyrrole nitrogen. From the far i.r. spectra amer configuration has been assigned to the indazole and 5-nitroindazole complexes.     

Synchronizing Steric and Electronic Effects in {RuII(NNNN,P)} Complexes: The Catalytic Dehydrative Alkylation of Anilines by Using Alcohols as a Case Study

A series of new hexacoordinated {Ru^II(NNNN,P)} complexes was prepared from [RuCl₂(R₃P)₃]. Their structure was determined by X‐ray crystallography. The catalytic potential of this new class of complexes was tested in the alkylation of aniline with benzyl alcohol. In this test reaction, the influence of the counteranion plus electronic influences at the tetradentate ligand and the phosphine ligand were examined. The electrochemistry of all complexes was studied by cyclic voltammetry. Depending on the substituent at the ligand backbone, the complexes showed a different behavior. For all N‐benzyl substituted complexes, reversible Ru^II/III redox potentials were observed, whereas the N‐methyl substituted complex possessed an irreversible oxidation event at small scan rates. Furthermore, the electronic influence of different substituents at the ligand scaffold and at the phosphine on the Ru^II/III redox potential was investigated. The measured E₀ values were correlated to the theoretically determined HOMO energies of the complexes. In addition, these HOMO energies correlated well with the reactivity of the single complexes in the alkylation of aniline with benzyl alcohol. The exact balance of redox potential and reactivity appears to be crucial for synchronizing the multiple hydrogen‐transfer events. The optimized catalyst structure was applied in a screening on scope and limitation in the catalytic dehydrative alkylation of anilines by using alcohols.     

Ruthenium(II)/(III) complexes of bidentate acetyl hydrazide Schiff bases

A series of octahedral Ru^II/Ru^III complexes of the type [Ru(Y)(CO)(BAX)(PPh₃)₂] and [RuCl₂(BAX)(PPh₃)₂] (Y = H or Cl; BAX = benzaldehydeacetylhydrazone anion; X = H, Me, OMe, OH, Cl or NO₂) have been prepared and characterised by spectral, magnetic and cyclic voltammetric studies. The Ru^II complexes are low spin diamagnetic (S = 0) whereas the Ru^III complexes are low spin and paramagnetic (S = 1/2). These Ru^II and Ru^III complexes absorb in the visible region respectively at ca. 16,000 and 28,000 cm^–1 which bands are assigned to the MLCT. The correlation of the _max values of the Ru^III complexes with the ⁺ Hammett parameter, is linear, indicating the profound effect of substituents on the electron density of the central metal. I.r. spectral data reveals that the hydrazone is chelated to ruthenium through the hydrazinic nitrogen and the deprotonated enolic oxygen. The rhombic nature of the e.s.r. spectra of the Ru^III complexes indicates an asymmetry in the electronic environment around the Ru atom. Ru^II complexes in CH₂Cl₂ show an irreversible Ru^II/III redox couple at ca. 0.9–0.5 V, while the Ru^III complexes show two reversible redox couples in the –0.1–0.1 and 0.8–0.6 V range, indicating that the higher oxidation state of ruthenium is stabilised by hydrazones.     

Controlling the Direction of the Molecular Axis of Rod‐Shaped Binuclear Ruthenium Complexes on Single‐Walled Carbon Nanotubes

We report the synthesis of a mixed‐valence ruthenium complex, bearing pyrene moieties on one side of the ligands as anchor groups. Composites consisting of mixed‐valence ruthenium complexes and SWNTs were prepared by noncovalent π–π interactions between the SWNT surface and the pyrene anchors of the Ru complex. In these composites, the long axis of the Ru complexes was aligned in parallel to the principal direction of the SWNT. The optimized conformation of these complexes on the SWNT surface was calculated by molecular mechanics. The composites were examined by UV/Vis absorption and FT‐IR spectroscopy, XPS, and SEM analysis. Furthermore, their electrochemical properties were evaluated. Cyclic voltammograms of the composites showed reversible oxidation waves at peak oxidation potentials (Ep_ox) = 0.86 and 1.08 V versus Fc⁺/Fc, which were assigned to the Ru^II‐Ru^II/Ru^II‐Ru^III and the Ru^II‐Ru^III/Ru^III‐Ru^III oxidation events of the dinuclear ruthenium complex, respectively. Based on these observations, we concluded that the electrochemical properties and mixed‐valence state of the dinuclear ruthenium complexes were preserved upon attachment to the SWNT surface.     

Stabilization of High‐Valence Ruthenium with Silicotungstate Ligands: Preparation,Structural Characterization,and Redox Studies of Ruthenium(III)‐Substituted α‐Keggin‐Type Silicotungstates with Pyridine Ligands, [SiW11O39RuIII(Py)]5−

Ruthenium(III)‐substituted α‐Keggin‐type silicotungstates with pyridine‐based ligands, [SiW₁₁O₃₉Ru^III(Py)]^5?, (Py: pyridine ( 1 ), 4‐pyridine‐carboxylic acid ( 2 ), 4,4′‐bipyridine ( 3 ), 4‐pyridine‐acetamide ( 4 ), and 4‐pyridine‐methanol ( 5 )) were prepared by reacting [SiW₁₁O₃₉Ru^III(H₂O)]^5? with the pyridine derivatives in water at 80 °C and then isolated as their hydrated cesium salts. These compounds were characterized using cyclic voltammetry (CV), UV/Vis, IR, and ¹H NMR spectroscopy, elemental analysis, titration, and X‐ray absorption near‐edge structure (XANES) analysis (Ru K‐edge and L₃‐edge). Single‐crystal X‐ray analysis of compounds 2 , 3 , and 4 revealed that Ru^III was incorporated in the α‐Keggin framework and was coordinated by pyridine derivatives through a Ru? N bond. In the solid state, compounds 2 and 3 formed a dimer through π? π interaction of the pyridine moieties, whereas they existed as monomers in solution. CV indicated that the incorporated Ru^III–Py was reversibly oxidized into the Ru^IV–Py derivative and reduced into the Ru^II–Py derivative.     

Ruthenium coordination preferences in imidazole‐containing systems revealed by electrospray ionization mass spectrometry and molecular modeling: Possible cues for the surprising stability of the Ru (III)/tris (hydroxymethyl)‐aminomethane/imidazole complexes

Ruthenium is a platinoid that exhibits a range of unique chemical properties in solution, which are exploited in a variety of applications, including luminescent probes, anticancer therapies, and artificial photosynthesis. This paper focuses on a recently demonstrated ability of this metal in its +3 oxidation state to form highly stable complexes with tris (hydroxymethyl)aminomethane (H₂NC(CH₂OH)₃, Tris‐base or T) and imidazole (Im) ligands, where a single Ru^III cation is coordinated by two molecules of each T and Im. High‐resolution electrospray ionization mass spectrometry (ESI MS) is used to characterize Ru^III complexes formed by placing a Ru^II complex [(NH₃)₅Ru^IICl]Cl in a Tris buffer under aerobic conditions. The most abundant ionic species in ESI MS represent mononuclear complexes containing an oxidized form of the metal, ie, [X_nRu^IIIT₂ – 2H]⁺, where X could be an additional T (n = 1) or NH₃ (n = 0‐2). Di‐ and tri‐metal complexes also give rise to a series of abundant ions, with the highest mass ion representing a metal complex with an empirical formula Ru₃C₂₄O₂₁N₆H₆₆ (interpreted as cyclo(T₂RuO)₃, a cyclic oxo‐bridged structure, where the coordination sphere of each metal is completed by two T ligands). The empirical formulae of the binuclear species are consistent with the structures representing acyclic fragments of cyclo(T₂RuO)₃ with addition of various combinations of ammonia and dioxygen as ligands. Addition of histidine in large molar excess to this solution results in complete disassembly of poly‐nuclear complexes and gives rise to a variety of ionic species in the ESI mass spectrum with a general formula [Ru^IIIHis_kT_m (NH₃)_n ? 2H]⁺, where k = 0 to 2, m = 0 to 3, and n = 0 to 4. Ammonia adducts are present for all observed combinations of k and m, except k = m = 2, suggesting that [His₂Ru^IIIT₂ ? 2H]⁺ represents a complex with a fully completed coordination sphere. The observed cornucopia of Ru^III complexes formed in the presence of histidine is in stark contrast to the previously reported selective reactivity of imidazole, which interacts with the metal by preserving the RuT₂ core and giving rise to a single abundant ruthenium complex (represented by [Im₂Ru^IIIT₂ ? 2H]⁺ in ESI mass spectra). Surprisingly, the behavior of a hexa‐histidine peptide (HHHHHH) is similar to that of a single imidazole, rather than a single histidine amino acid: The RuT₂ core is preserved, with the following ionic species observed in ESI mass spectra: [HHHHHH·(Ru^IIIT₂)_m ? (3m‐1)H]⁺ (m = 1‐3). The remarkable selectivity of the imidazole interaction with the Ru^IIIT₂ core is rationalized using energetic considerations at the quantum mechanical level of theory.     

Heteropentanuclear Oxalato‐Bridged nd–4f (n=4, 5) Metal Complexes with NO Ligand: Synthesis,Crystal Structures,Aqueous Stability and Antiproliferative Activity

A series of heteropentanuclear oxalate‐bridged Ru(NO)‐Ln (4d–4f) metal complexes of the general formula (nBu₄N)₅[Ln{RuCl₃(μ‐ox)(NO)}₄], where Ln=Y ( 2 ), Gd ( 3 ), Tb ( 4 ), Dy ( 5 ) and ox=oxalate anion, were obtained by treatment of (nBu₄N)₂[RuCl₃(ox)(NO)] ( 1 ) with the respective lanthanide salt in 4:1 molar ratio. The compounds were characterized by elemental analysis, IR spectroscopy, electrospray ionization (ESI) mass spectrometry, while 1 , 2 , and 5 were in addition analyzed by X‐ray crystallography, 1 by Ru K‐edge XAS and 1 and 2 by ¹³C NMR spectroscopy. X‐ray diffraction showed that in 2 and 5 four complex anions [RuCl₃(ox)(NO)]^2? are coordinated to Y^III and Dy^III, respectively, with formation of [Ln{RuCl₃(μ‐ox)(NO)}₄]^5? (Ln=Y, Dy). While Y^III is eight‐coordinate in 2 , Dy^III is nine‐coordinate in 5 , with an additional coordination of an EtOH molecule. The negative charge is counterbalanced by five nBu₄N⁺ ions present in the crystal structure. The stability of complexes 2 and 5 in aqueous medium was monitored by UV/Vis spectroscopy. The antiproliferative activity of ruthenium‐lanthanide complexes 2 – 5 were assayed in two human cancer cell lines (HeLa and A549) and in a noncancerous cell line (MRC‐5) and compared with those obtained for the previously reported Os(NO)‐Ln (5d–4f) analogues (nBu₄N)₅[Ln{OsCl₃(ox)(NO)}₄] (Ln=Y ( 6 ), Gd ( 7 ), Tb ( 8 ), Dy ( 9 )). Complexes 2 – 5 were found to be slightly more active than 1 in inhibiting the proliferation of HeLa and A549 cells, and significantly more cytotoxic than 5d–4f metal complexes 6 – 9 in terms of IC₅₀ values. The highest antiproliferative activity with IC₅₀ values of 20.0 and 22.4 μM was found for 4 in HeLa and A549 cell lines, respectively. These cytotoxicity results are in accord with the presented ICP‐MS data, indicating five‐ to eightfold greater accumulation of ruthenium versus osmium in human A549 cancer cells.     

α-Synuclein as a Target for Metallo-Anti-Neurodegenerative Agents

The unique thermodynamic and kinetic coordination chemistry of ruthenium allows it to modulate key adverse aggregation and membrane interactions of α-synuclein (α-syn) associated with Parkinson's disease. We show that the low-toxic Ru^III complex trans-[ImH][RuCl₄(Me₂SO)(Im)] (NAMI-A) has dual inhibitory effects on both aggregation and membrane interactions of α-syn with submicromolar affinity, and disassembles pre-formed fibrils. NAMI-A abolishes the cytotoxicity of α-syn towards neuronal cells and mitigates neurodegeneration and motor impairments in a rat model of Parkinson's. Multinuclear NMR and MS analyses show that NAMI-A binds to residues involved in protein aggregation and membrane binding. NMR studies reveal the key steps in pro-drug activation and the effect of activated NAMI-A species on protein folding. Our findings provide a new basis for designing ruthenium complexes which could mitigate α-syn-induced Parkinson's pathology differently from organic agents.     

Synthesis and spectral studies on heterobimetallic complexes of manganese and ruthenium derived from N-(2-hydroxynaphthalen-1-yl)methylenebenzoylhydrazide

The complex [Mn^IV(napbh)₂] (napbhH₂ = N-(2-hydroxynaphthalen-1-yl)methylenebenzoylhydrazide) reacts with activated ruthenium(III) chloride in methanol in 1 : 1.2 molar ratio under reflux, giving heterobimetallic complexes, [Mn^IV(napbh)₂Ru^IIICl₃(H₂O)] · [Ru^III(napbhH)Cl₂(H₂O)] reacts with Mn(OAc)₂·4H₂O in methanol in 1 : 1.2 molar ratio under reflux to give [Ru^III(napbhH)Cl₂(H₂O)Mn^II(OAc)₂]. Replacement of aquo in these heterobimetallic complexes has been observed when the reactions are carried out in the presence of pyridine (py), 3-picoline (3-pic), or 4-picoline (4-pic). The molar conductances for these complexes in DMF indicates 1 : 1 electrolytes. Magnetic moment values suggest that these heterobimetallic complexes contain Mn^IV and Ru^III or Ru^III and Mn^II in the same structural unit. Electronic spectral studies suggest six coordinate metal ions. IR spectra reveal that the napbhH₂ ligand coordinates in its enol form to Mn^IV and bridges to Ru^III and in the keto form to Ru^III and bridging to Mn^II.     

Triphenylamine and carbazole‐modified iridiumIII 2‐phenylpyridine complexes: Synthesis,anticaner application and targeted research

Four half‐sandwich iridium^III (Ir^III) triphenylamine or carbazole‐modified 2‐phenylpyridine (TPA/Cz‐PhPy) complexes ([(η⁵‐Cp*)Ir(C^N)Cl]) were synthesized and characterized. Compared with cisplatin, these complexes show higher activity to A549, HepG2 and HeLa cells, with the IC₅₀ values changed from 2.5 ± 0.1 μM to 14.8 ± 2.6 μM. Additionally, complexes could effectively prevent the migration of cancer cells. Ir^III TPA/Cz‐PhPy complexes could bind to protein and transport through serum protein, catalyze the oxidation of nicotinamide‐adenine dinucleotid (NADH) and induce the accumulation of reactive oxygen species, and eventually lead to apoptosis, which was also confirmed by flow cytometry. Moreover, prominent targeted fluorescence property confirmed that Ir^III TPA/Cz‐PhPy complexes were involved in non‐energy dependent intracellular uptake mechanism, effectively accumulated in lysosomes and damage the integrity of acidic lysosomes, and eventually induce cell death. Above all, TPA/Cz‐appended half‐sandwich Ir^III phenylpyridine complexes are promising anticancer agents with dual functions, including migration inhibition and lysosomal damage.     

Tuning the Cellular Uptake Properties of Luminescent Heterobimetallic Iridium(III)–Ruthenium(II) DNA Imaging Probes

The synthesis of two new luminescent dinuclear Ir^III–Ru^II complexes containing tetrapyrido[3,2‐a:2′,3′‐c:3′′,2′′‐h:2′′′,3′′′‐j]phenazine (tpphz) as the bridging ligand is reported. Unlike many other complexes incorporating cyclometalated Ir^III moieties, these complexes display good water solubility, allowing the first cell‐based study on Ir^III–Ru^II bioprobes to be carried out. Photophysical studies indicate that emission from each complex is from a Ru^II excited state and both complexes display significant in vitro DNA‐binding affinities. Cellular studies show that each complex is rapidly internalised by HeLa cells, in which they function as luminescent nuclear DNA‐imaging agents for confocal microscopy. Furthermore, the uptake and nuclear targeting properties of the complex incorporating cyclometalating 2‐(4‐fluorophenyl)pyridine ligands around its Ir^III centre is enhanced in comparison to the non‐fluorinated analogue, indicating that fluorination may provide a route to promote cell uptake of transition‐metal bioprobes.     

Spectroscopic and magnetic studies on electrogenerated mixed-valence ruthenium complexes

Electrochemical synthesis has enabled several sequences of triple chloride bridged diruthenium complexes of general type [L_3?xCl_xRuCl₃RuCl_yL_3?y]^z/z+1/z+2 (L = soft neutral ligand) to be generated. The intervalence charge transfer bands in the optical spectra of the mixed-valence Ru^II,III₂ compounds and variable temperature magnetic measurements for the corresponding Ru^III.III₂ complexes reveal that the degree of metal—metal interaction in these confacial bioctahedral systems decreases as the molecular asymmetry (y?x) increases.     

(Acetonitrile){2,6‐bis[1‐(2,4,6‐trimethylphenylimino)ethyl]pyridine}dichloridoruthenium(II) dichloromethane solvate

In the title compound, [RuCl₂(C₂H₃N)(C₂₇H₃₁N₃)]·CH₂Cl₂, the Ru^II ion is six‐coordinated in a distorted octahedral arrangement, with the two Cl atoms located in the apical positions, and the pyridine (py) N atom, the two imino N atoms and the acetonitrile N atom located in the basal plane. The two equatorial Ru—N_imino distances are almost equal (mean 2.087 Å) and are substantially longer than the equatorial Ru—N_py bond [1.921 (4) Å]. It is observed that the N_imino—M—N_py angle for the five‐membered chelate rings of pyridine‐2,6‐diimine complexes is inversely related to the magnitude of the M—N_py bond. The title structure is stabilized by intra‐ and intermolecular C—H...Cl hydrogen bonds, as well as by van der Waals interactions.     

Synthesis,Characterization, Catalytic and Antibacterial Activity of Two Series of Dinuclear Ruthenium Sulphoxide Complexes Using 5,5¢‐Methylenebis(pyridine) as Bis‐chelating Bridging Ligand

The reaction of a new heterocyclic bidentate N containing spacer, (ligand) 5,5′‐methylenebis(pyridine) with ruthenium sulphoxide precursors resulted, dinuclear complexes. We herein report three formulations; [{cis,fac‐RuCl₂(so)₃}₂(μ‐mbp)].3so; [{trans,mer‐RuCl₂(so)₃₂}₂(μ‐mbp)].3so and [{trans‐RuCl₄(so)}₂(μ‐mbp)]^2?[X]₂⁺; where so = dimethyl‐sulfoxide/tetramethylenesulfoxide; mbp = 5,5′‐methylenebis(pyridine) and [X]⁺ = [(dmso)₂H]⁺, Na⁺ or [(tmso)H]⁺. These complexes were characterized on the basis of elemental analyses, molar conductance measurement, magnetic susceptibility, FT‐IR, ¹H‐NMR, ¹³C{¹H}‐NMR, electronic spectroscopy and FAB‐Mass spectrometry. Catalytic activity of these complexes has been investigated in hydrolysis of benzonitrile. All the complexes exhibit good antibacterial activity against gram‐negative bacteria Escherichia coli in comparison to Chloramphenicol.     

The mer-[RuCl3(dppb)(H2O)] complex: A versatile tool for synthesis of Ru compounds

The complex mer-[RuCl₃(dppb)(H₂O)] [dppb = 1,4-bis(diphenylphosphino)butane] was used as a precursor in the synthesis of the complexes tc-[RuCl₂(CO)₂(dppb)], ct-[RuCl₂(CO)₂(dppb)], cis-[RuCl₂(dppb)(Cl-bipy)], [RuCl(2Ac4mT)(dppb)] (2Ac4mT = N(4)-meta-tolyl-2-acetylpyridine thiosemicarbazone ion) and trans-[RuCl₂(dppb)(mang)] (mang = mangiferin or 1,3,6,7-tetrahydroxyxanthone-C2-β-D-glucoside) complexes. For the synthesis of Ru^II complexes, the Ru^III atom in mer-[RuCl₃(dppb)(H₂O)] may be reduced by H₂(g), forming the intermediate [Ru₂Cl₄(dppb)₂], or by a ligand (such as H2Ac4mT or mangiferin). The X-ray structures of the cis-[RuCl₂(dppb)(Cl-bipy)], tc-[RuCl₂(CO)₂(dppb)] and [RuCl(2Ac4mT)(dppb)] complexes were determined.     

Ru(II)–DMSO complexes containing aromatic and heterocyclic acid hydrazides: Structure,electrochemistry and biological activity

The reaction of cis-[RuCl₂(DMSO)₄] with a family of aromatic and heterocyclic acid hydrazides yielded new complexes of the general formula trans-[RuCl₂(DMSO)₂(hydrazide)] · nH₂O (n = 0; 1–6; n = 1; 7). The new complexes have been characterized by IR, UV–Vis and ¹H NMR spectroscopic methods. In addition, the structure of one of the complexes, [RuCl₂(DMSO)₂(tcah)] · H₂O (tcah = thiophene-2-carboxylic acid hydrazide), has been determined by single crystal X-ray diffraction. All the studies reveal the neutral bidentate coordination of the hydrazide ligands through the acyl oxygen and amine nitrogen atoms. The electron transfer properties of the complexes were studied by cyclic voltammetry and all the complexes except one show an irreversible/quasi-reversible reduction wave (Ru^II/Ru^I) and an uncoupled oxidation peak (Ru^III/ Ru^II). The preliminary DNA-binding ability of the complexes, studied with herring sperm DNA, shows the binding of the complexes with DNA with a lesser affinity than classical intercalators. The complexes have also been screened for their antibacterial activity against five pathogenic bacteria.